AU4657697A - Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) - Google Patents
Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)Info
- Publication number
- AU4657697A AU4657697A AU46576/97A AU4657697A AU4657697A AU 4657697 A AU4657697 A AU 4657697A AU 46576/97 A AU46576/97 A AU 46576/97A AU 4657697 A AU4657697 A AU 4657697A AU 4657697 A AU4657697 A AU 4657697A
- Authority
- AU
- Australia
- Prior art keywords
- inhibitory factor
- mpif
- cif
- mip
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100036850 C-C motif chemokine 23 Human genes 0.000 title 1
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 title 1
- 108010030175 colony inhibiting factor Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 210000002540 macrophage Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000001616 monocyte Anatomy 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15446/02A AU775308B2 (en) | 1996-09-30 | 2002-02-06 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
AU15445/02A AU777297B2 (en) | 1996-09-30 | 2002-02-06 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2729996P | 1996-09-30 | 1996-09-30 | |
US2730096P | 1996-09-30 | 1996-09-30 | |
US50027300 | 1996-09-30 | ||
US60027299 | 1996-09-30 | ||
PCT/US1997/017505 WO1998014582A1 (en) | 1996-09-30 | 1997-09-30 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15445/02A Division AU777297B2 (en) | 1996-09-30 | 2002-02-06 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
AU15446/02A Division AU775308B2 (en) | 1996-09-30 | 2002-02-06 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4657697A true AU4657697A (en) | 1998-04-24 |
Family
ID=26702293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46576/97A Abandoned AU4657697A (en) | 1996-09-30 | 1997-09-30 | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0941330A1 (zh) |
JP (1) | JP2001500382A (zh) |
KR (1) | KR20030097607A (zh) |
CN (1) | CN1239510A (zh) |
AU (1) | AU4657697A (zh) |
CA (1) | CA2267193A1 (zh) |
NZ (2) | NZ335003A (zh) |
WO (1) | WO1998014582A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU775308B2 (en) * | 1996-09-30 | 2004-07-29 | Human Genome Sciences, Inc. | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811773B1 (en) | 1993-12-22 | 2004-11-02 | Human Genome Sciences, Inc. | Human monocyte colony inhibitory factor (M-CIF) polypeptides |
US6001606A (en) * | 1994-03-08 | 1999-12-14 | Human Genome Sciences, Inc. | Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby |
US6451562B1 (en) | 1993-12-22 | 2002-09-17 | Human Genome Sciences, Inc. | Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
US6488925B2 (en) | 1993-12-22 | 2002-12-03 | Human Genome Sciences, Inc. | Macrophage inflammatory protein-4 (MIP-4) polypeptides |
US6495129B1 (en) | 1994-03-08 | 2002-12-17 | Human Genome Sciences, Inc. | Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) |
US6632425B1 (en) | 1997-03-20 | 2003-10-14 | Human Genome Sciences, Inc. | Chemokine compositions |
CA2350771A1 (en) | 1998-11-10 | 2000-05-18 | Human Genome Sciences, Inc. | Chemokine .beta.-7 |
AU1891000A (en) * | 1999-01-07 | 2000-07-24 | Takeda Chemical Industries Ltd. | Process for producing activated protein |
AU1083401A (en) * | 1999-10-14 | 2001-04-23 | Human Genome Sciences, Inc. | Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
EP1176200A3 (de) | 2000-06-20 | 2005-01-12 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen |
US20030096260A1 (en) * | 2001-10-09 | 2003-05-22 | Zhenhua Miao | Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
US20030215460A1 (en) | 2002-05-07 | 2003-11-20 | Schall Thomas J. | Methods and compositions for inducing an immune response |
KR100867257B1 (ko) * | 2001-10-09 | 2008-11-11 | 케모센트릭스, 인크. | 포밀 펩티드 수용체 유사 1 수용체에 대한 리간드로유용한 조성물 및 이의 사용 방법 |
US20070244037A1 (en) * | 2003-10-24 | 2007-10-18 | Tap Pharmaceutical Products Inc | Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation |
US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
WO2005093428A2 (en) * | 2004-03-22 | 2005-10-06 | Novartis Ag | Chemokine ccl18 as a biomarker |
US8221995B2 (en) | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
JP5272011B2 (ja) * | 2007-10-22 | 2013-08-28 | セントビンセンツ ホスピタル シドニー リミテッド | 予後判定の方法 |
CN113215085B (zh) * | 2021-05-07 | 2024-05-10 | 澳门大学 | 一种脂类物质添加剂及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ271756A (en) * | 1993-12-22 | 1998-02-26 | Human Genome Sciences Inc | Human macrophage inflammatory proteins and coding sequences, their production and use |
JP3630685B2 (ja) * | 1993-12-24 | 2005-03-16 | ウルフ−ゲオルグ フォースマン | ヒト循環サイトカインcc−1 |
US5602008A (en) * | 1994-11-29 | 1997-02-11 | Incyte Pharmaceuticals, Inc. | DNA encoding a liver expressed chemokine |
EP0871672A4 (en) * | 1995-05-05 | 1999-05-12 | Human Genome Sciences Inc | CHIMIOKINE BETA-8, CHIMIOKINE BETA-1 AND PROTEIN 4 INFLAMMATORY FROM HUMAN ORIGINAL MACROPHAGES |
EP0859842A4 (en) * | 1995-09-29 | 1999-02-24 | Smithkline Beecham Corp | SHORT FORMS OF CHEMOKIN-g (b) -8 |
ZA968897B (en) * | 1995-10-24 | 1998-07-14 | Smithkline Beecham Corp | Novel chemokine for mobilizing stem cells |
-
1997
- 1997-09-30 JP JP10516753A patent/JP2001500382A/ja not_active Withdrawn
- 1997-09-30 CN CN97199629A patent/CN1239510A/zh active Pending
- 1997-09-30 CA CA002267193A patent/CA2267193A1/en not_active Abandoned
- 1997-09-30 NZ NZ335003A patent/NZ335003A/xx unknown
- 1997-09-30 NZ NZ506135A patent/NZ506135A/xx unknown
- 1997-09-30 WO PCT/US1997/017505 patent/WO1998014582A1/en not_active Application Discontinuation
- 1997-09-30 KR KR1020027012833A patent/KR20030097607A/ko not_active Application Discontinuation
- 1997-09-30 AU AU46576/97A patent/AU4657697A/en not_active Abandoned
- 1997-09-30 EP EP97945352A patent/EP0941330A1/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU775308B2 (en) * | 1996-09-30 | 2004-07-29 | Human Genome Sciences, Inc. | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
AU777297B2 (en) * | 1996-09-30 | 2004-10-07 | Human Genome Sciences, Inc. | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
Also Published As
Publication number | Publication date |
---|---|
CN1239510A (zh) | 1999-12-22 |
NZ335003A (en) | 2000-11-24 |
CA2267193A1 (en) | 1998-04-09 |
JP2001500382A (ja) | 2001-01-16 |
NZ506135A (en) | 2002-11-26 |
KR20030097607A (ko) | 2003-12-31 |
EP0941330A1 (en) | 1999-09-15 |
WO1998014582A1 (en) | 1998-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4657697A (en) | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) | |
AU5698098A (en) | Video decoder with interleaved data processing | |
AU5171696A (en) | Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism | |
AU5175999A (en) | Anesthetic injection apparatus | |
AU2459697A (en) | Anaerobic treatment process | |
AU1849697A (en) | Medical diagnostic apparatus with sleep mode | |
AU4792593A (en) | Single-chamber cleaning, rinsing and drying apparatus | |
HUP9901082A3 (en) | Moist bacteriocin disinfectant wipe, producing and using the same | |
AU4232097A (en) | Set screw for use with osteosynthesis apparatus | |
AU4734497A (en) | Graft survival prolongation with porphyrins | |
IT237066Y1 (it) | Seggiolone con meccanismo perfezionato di reclinamento | |
AU1041097A (en) | Encoder, decoder and methods used therefor | |
AU1743495A (en) | Composition for wound healing, neuron growth and vascularization | |
NO20031525D0 (no) | Kjemokinmutanter i behandlingen av multippel sklerose | |
AU5106696A (en) | Novel, defined enzyme mixtures for obtaining cells and for wound treatment | |
AU7552098A (en) | Physiologically active substances tkr2449, process for producing the same, and microorganism | |
CA2221255A1 (en) | Use of selegiline to treat hearing loss in mammals | |
AU2001236858A1 (en) | Distribution, processing, and reconstruction of variable-sized images using multiple processor arrays | |
AU2553397A (en) | Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring | |
AU5581298A (en) | Modified human factor xa | |
AU2303495A (en) | Preservative for wood, treating solutions and use of the preservative | |
AU5974999A (en) | Hair treatment composition, method and use | |
AU2001275959A1 (en) | Method of treating the syndrome of type 2 diabetes in humans | |
WO2000048584A3 (en) | Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain | |
AU2763197A (en) | Dispenser unit, process for manufacturing the same and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |